HiSiaddi is an innovative foreign trade service provider driven by dual engines of technology transformation and foreign trade services. We have established a "1+2+3+4=1" service system and can supply raw materials of Coriolus Versicolor Extract from multiple well-known original manufacturers.
As a foreign trade enterprise with independent R&D capabilities, HiSiaddi has conducted repeated multi-round inspections of Coriolus Versicolor Extract manufacturers and acquired objective, in-depth insights into different brands. We regularly analyze various Coriolus Versicolor Extract manufacturers for clients to help them select matching products. Below is a brand recommendation case.
Please contact HiSiaddi customer service if you require further comparative analysis of brands and product models.
The buyer is NaturaMed GmbH, headquartered in Munich, Germany — a leading enterprise supplying premium pharmacies, private wellness hospitals and organic health chains across the DACH region, specializing in raw materials for high-end immune capsules and oral liquid dietary supplements. Its products comply with EU EC396 pesticide residue standards, Germany’s LFGB food pharmacopoeia and USP raw material specifications, and the company rejects low-grade generic raw materials from China. It previously imported pharmaceutical-grade Coriolus Versicolor Extract from Switzerland year-round. Driven by surging European raw material prices and extended lead times, it plans to source 8.2 tons of Coriolus Versicolor Extract from designated Chinese suppliers annually, split into two major categories: pharmaceutical powder for capsules and cold-water-soluble powder for oral liquids. Mandatory indicators: total polysaccharides ≥30%, β-glucan ≥18%, clearly labeled PSP/PSK active components, no exogenous filler auxiliary materials.
The client independently contacted four leading domestic plant extract manufacturers for inquiries and samples yet encountered sourcing difficulties: each manufacturer only promoted its own products, politely evaded objective comparisons of peer strengths and declined to disclose competitor weaknesses. Lacking an industry database of Chinese manufacturers, the client could not distinguish the matching end-scenarios of various brands and models. Five batches of samples sent to third-party laboratories in Germany exhibited inconsistent indicators, powder incompatible with production lines and chaotic quotation tiers, halting the sourcing process for nearly 45 days. The client entrusted HiSiaddi to leverage its domestic plant extract industry resources to horizontally dissect five mainstream mid-to-high-end manufacturers and their flagship product models, conduct neutral and objective cross-brand evaluations, and screen the optimal matching brand and specifications.
HiSiaddi selected five renowned export-oriented manufacturers: Layn Natural Ingredients, Chenguang Biotech, Sino Herb Bio, Zhejiang Fangge Pharmaceutical and Fujian Herb Treasure. We sorted out brand positioning, three flagship models, strengths, weaknesses and matching end-scenarios for each without bias toward any manufacturer:
· Model ① R-YZ30: General capsule grade, total polysaccharides 30%, β-glucan 18%, fruiting body feedstock, conventional powder via high-temperature water extraction
· Model ② R-YZ50-HP: High-purity pharmaceutical grade, polysaccharides 50%, β-glucan 32%, low-temperature resin refining with enriched PSK
· Model ③ R-YZ-SOL: Water-soluble modified powder for oral liquids, cold-water instant dissolution via cyclodextrin modification Strengths: Largest export volume to Europe and the United States, complete overseas NDI filings, full controllability of pesticide residues; Weaknesses: Average powder flowability of conventional models, high purchase unit price for high-purity grades, high minimum order quantity for small-batch orders.
· Model ① CG-YZ30-F: Basic food capsule grade, polysaccharides 30%, mixed feedstock of forest-grown and standardized greenhouse fungi
· Model ② CG-YZ35-MED: Pharmaceutical refined powder, polysaccharides 35%, β-glucan 21%, 100% Changbai Mountain forest-grown raw materials
· Model ③ CG-YZ-LQ: Low-impurity powder for liquid beverages, deep protein removal refining Strengths: Self-owned Coriolus Versicolor cultivation bases, sufficient production capacity, stable lead times, large negotiation space for bulk orders; Weaknesses: Limited water-soluble modified product lines, restricted R&D production capacity for small customized specifications.
· Model ① SH-PSP30: PSP-enriched grade, polysaccharides 30%, prioritizing protein-bound polysaccharides, compatible with European immune oral liquids
· Model ② SH-PSK40: Pharmaceutical PSK grade, polysaccharides 40%, benchmark raw material compliant with Japanese Pharmacopoeia
· Model ③ SH-YZ-SF: Ultrafine capsule powder with optimized angle of repose, compatible with high-speed filling equipment Strengths: Precisely quantified PSP/PSK components, outstanding specialized fungal polysaccharide technology, flexible small-batch sampling; Weaknesses: Mass production capacity inferior to Chenguang and Layn, slightly higher raw material procurement costs.
· Model ① FG-YZ30-PH: Pharmacopoeia-grade raw material, mainstream specification for domestic pharmaceutical manufacturers
· Model ② FG-YZ40-EX: Concentrated high-purity powder via extraction, primarily used for hospital preparations Strengths: Long-term supporting supplier for domestic pharmaceutical plants, compliant with internal control standards of Chinese Pharmacopoeia; Weaknesses: Insufficient overseas compliance filings for Europe and America, immature water-soluble modified products, primary focus on domestic market with incomplete export supporting documents.
· Model ① HB-YZ30-WILD: 100% Wuyi Mountain wild-simulated forest Coriolus Versicolor feedstock, polysaccharides 30%
· Model ② HB-YZ45-ULTRA: High-purity powder via supercritical extraction, zero solvent residues Strengths: Fully traceable forest-grown raw materials, excellent pesticide residue and heavy metal indicators, organic raw material options available; Weaknesses: Limited production capacity, extended delivery cycles for large-volume orders, limited spot inventory.
Combining the client’s four core demands: dual production lines for capsules and oral liquids, stringent EU compliance, annual phased batch delivery, and balance of cost and active ingredient indicators, we eliminated Fangge Pharmaceutical (insufficient compliance) and Fujian Herb Treasure (unstable production capacity), ultimately selecting two mid-to-high-end manufacturers: Layn Natural Ingredients and Sino Herb Bio, covering three flagship models:
1. Layn R-YZ50-HP (High-purity pharmaceutical powder): Exclusively for the client’s premium hospital-exclusive capsule line, polysaccharides 50%, β-glucan 32%, complete FDA filings compatible with premium product positioning;
2. Sino Herb SH-PSP30 (PSP-enriched powder): Specialized raw material for oral liquids, PSP components meeting European dietary research standards, cold-water solubility matching the client’s sterile oral liquid production line;
3. Sino Herb SH-YZ-SF (Ultrafine capsule powder): Raw material for the client’s conventional mass-market capsules, excellent powder flowability for unobstructed automatic filling, balancing overall procurement costs.
· Layn: Resolves compliance and high-purity indicator pain points for premium hospital-exclusive products, leveraging mature European and American export qualifications for hassle-free German customs clearance;
· Sino Herb: Leverages specialized PSP technology advantages to match oral liquid formulas, flexible small-batch supplementary orders, segmented high/low-end raw material procurement to control overall costs;
· Chenguang eliminated: The client lacks ten-thousand-ton-level procurement volume, rendering Chenguang’s bulk-order cost advantages unutilizable; its water-soluble models fail to meet low-temperature storage requirements for oral liquids;
· Fangge and Herb Treasure eliminated due to respective compliance and production capacity weaknesses.
HiSiaddi coordinated free sample delivery of the three models from the two manufacturers, with unified testing at Germany’s SGS third-party laboratory under dual LFGB and EC396 standards, paired with small-scale trials on the client’s GMP production line:
· Layn R-YZ50-HP: Smooth capsule filling, stable active ingredient content, 99.2% qualification rate for premium line pilot production;
· Two Sino Herb models: Oral liquids remained clear with no precipitation or stratification after 90 days of storage at 4°C, with PSP content fully aligning with the client’s formula design.
All samples passed acceptance in one round, prompting the client to cancel sampling plans for remaining brands and sign an annual procurement framework for 8.2 tons: 3.7 tons of Layn high-purity powder, 2.8 tons of Sino Herb PSP oral liquid powder and 1.7 tons of Sino Herb ultrafine capsule powder, scheduled for production across 9 batches on demand per year. The first shipment of 2.1 tons departed Shanghai Port for Hamburg, passing random inspections by German customs and food safety authorities for one-time smooth warehousing.
In the subsequent year, the client added customized organic-certified Coriolus Versicolor Extract requirements, with HiSiaddi continuing to coordinate targeted development of new specifications by the two manufacturers. Compared with raw materials previously imported from Switzerland, overall procurement costs decreased by 27.8%, and sea freight lead time was cut by 60%.
It is common industry practice for major domestic raw material manufacturers to only promote their own products and avoid highlighting peer strengths due to commercial orientation. Mid-to-high-end European pharmaceutical enterprises are proficient in local drug administration regulations and product formulas yet lack awareness of technological segmentation, differentiated product models, capacity and compliance weaknesses among Chinese manufacturers, making independent sourcing highly prone to pitfalls.
As a neutral third-party foreign trade service provider unbound to the interests of a single factory, HiSiaddi conducts objective cross-brand horizontal evaluations and accurately matches product models based on clients’ end-product application scenarios, breaking information barriers between Chinese and foreign raw material markets and enabling high-end domestic Coriolus Versicolor raw materials to steadily enter Europe’s mid-to-high-end dietary supplement supply chain.
Please contact HiSiaddi customer service if you require further comparative analysis of brands and product models.
+86-13120989737 
info@hisiaddi.com 
English
